ReadingResearchRadarInvestment framework
Sign in / Sign up
← Back to reading
NewsQuick take1 min readDisconfirmAI Editorial

Ex-Swappie CEO's AI Health Startup Treat Raises €3M Pre-Seed

Helsinki-based AI healthtech startup Treat closed a €3 million pre-seed round led by byFounders and Illusian to tackle diagnostic inefficiencies.

2026-11-17 14:00 GMT+8

Treat, an AI-focused healthtech company based in Helsinki, has raised €3 million in a pre-seed funding round led by byFounders and Illusian. Illusian is the investment vehicle of Supercell co-founder Ilkka Paananen.

The Finnish startup was founded in 2026 by Sami Marttinen, former CEO of Swappie, along with medical doctor Antti Mauno and fintech engineering lead Onni Wahlberg. The platform uses AI to gather patient symptoms and check insurance coverage, connecting patients to licensed doctors within minutes once their medical history has been reviewed.

Marttinen cited his wife's experience of nine private doctor visits before receiving a diagnosis as the inspiration. He argues that the current economic model rewards repeat visits rather than efficient resolution. Treat claims that 83% of cases are resolved on the first visit and states that no patient records are shared with public LLMs.

The funding round closed just one week after the first conversation. The capital will primarily go toward product development and expansion. Treat currently has over 20 pilot employer customers and expects to be active in more than five countries by the end of the year.

Sources

  • techfundingnews.comTech Funding News↗
Sign in / Sign up
ReadingResearchRadarInvestment framework
Continue researching →